A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors
Conditions: Advanced Solid Tumor (Phase 1); Pancreas Adenocarcinoma; Non-small Cell Lung Cancer; Malignant Melanoma (Cutaneous) Interventions: Drug: IMM-6-415 Sponsors: Immuneering Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Lung Cancer | Melanoma | Non-Small Cell Lung Cancer | Pancreas | Pancreatic Cancer | Research | Skin Cancer | Study